MElkin pharma continues the preclinical development of its drug candidates. The company seeks to raise funds to finance the next development stages of its lead compound.
Partnering is a key point of our core strategy. The Company is still engaged in identifying optimal business opportunities regarding products or projects of its pipeline. In this way, we consider to validate partnering or out-licensing with a Pharma company who will conduct the final clinical trials leading to regulatory approval and finally commercialization.
For information regarding partnering opportunities with MElkin pharma, please contact us at email@example.com